David Benjamin Kantor, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Asthma | 10 | 2023 | 6274 | 1.240 |
Why?
|
| Quadriceps Muscle | 2 | 2021 | 157 | 1.200 |
Why?
|
| Rhinovirus | 3 | 2023 | 210 | 1.020 |
Why?
|
| Critical Illness | 4 | 2024 | 2754 | 0.790 |
Why?
|
| Picornaviridae Infections | 2 | 2023 | 97 | 0.680 |
Why?
|
| Fluid Therapy | 2 | 2024 | 585 | 0.630 |
Why?
|
| Extravascular Lung Water | 1 | 2018 | 21 | 0.610 |
Why?
|
| Blood Gas Monitoring, Transcutaneous | 1 | 2018 | 34 | 0.610 |
Why?
|
| Echocardiography | 4 | 2024 | 5043 | 0.560 |
Why?
|
| Thigh | 1 | 2017 | 239 | 0.520 |
Why?
|
| Terbutaline | 1 | 2014 | 26 | 0.460 |
Why?
|
| Immunoglobulin E | 3 | 2023 | 1510 | 0.460 |
Why?
|
| Critical Care | 6 | 2021 | 2717 | 0.450 |
Why?
|
| Adrenergic beta-2 Receptor Agonists | 1 | 2014 | 110 | 0.430 |
Why?
|
| Catheterization, Peripheral | 1 | 2016 | 346 | 0.420 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2013 | 277 | 0.410 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2016 | 578 | 0.380 |
Why?
|
| Ultrasonography, Interventional | 2 | 2016 | 1520 | 0.370 |
Why?
|
| Bronchodilator Agents | 1 | 2014 | 519 | 0.350 |
Why?
|
| Pediatrics | 4 | 2019 | 3622 | 0.340 |
Why?
|
| Education, Medical, Graduate | 2 | 2018 | 2411 | 0.300 |
Why?
|
| Axons | 3 | 2005 | 1678 | 0.270 |
Why?
|
| Intensive Care Units, Pediatric | 3 | 2024 | 1024 | 0.250 |
Why?
|
| Point-of-Care Systems | 3 | 2021 | 1227 | 0.250 |
Why?
|
| Respiratory Insufficiency | 1 | 2014 | 1244 | 0.240 |
Why?
|
| Ultrasonography | 6 | 2021 | 5994 | 0.240 |
Why?
|
| Child | 16 | 2024 | 80856 | 0.230 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 2004 | 142 | 0.230 |
Why?
|
| Heparan Sulfate Proteoglycans | 1 | 2004 | 112 | 0.230 |
Why?
|
| Enterovirus Infections | 1 | 2023 | 74 | 0.210 |
Why?
|
| Vasoconstrictor Agents | 1 | 2024 | 658 | 0.170 |
Why?
|
| Nervous System | 1 | 2003 | 547 | 0.170 |
Why?
|
| Convalescence | 1 | 2018 | 109 | 0.150 |
Why?
|
| Genetic Variation | 1 | 2013 | 6607 | 0.150 |
Why?
|
| Nerve Tissue Proteins | 3 | 2005 | 4417 | 0.140 |
Why?
|
| Breath Tests | 1 | 2018 | 300 | 0.140 |
Why?
|
| Heart | 2 | 2020 | 4451 | 0.140 |
Why?
|
| Acute Disease | 2 | 2018 | 7245 | 0.140 |
Why?
|
| Adolescent | 7 | 2024 | 89163 | 0.130 |
Why?
|
| Venae Cavae | 1 | 2015 | 41 | 0.130 |
Why?
|
| Boston | 3 | 2018 | 9359 | 0.130 |
Why?
|
| Long-Term Potentiation | 1 | 1996 | 290 | 0.120 |
Why?
|
| Severity of Illness Index | 3 | 2018 | 15965 | 0.120 |
Why?
|
| Carbon Monoxide | 1 | 2018 | 551 | 0.120 |
Why?
|
| Endothelium | 1 | 1996 | 768 | 0.110 |
Why?
|
| Child, Preschool | 4 | 2024 | 42620 | 0.110 |
Why?
|
| Nitric Oxide Synthase | 1 | 1996 | 911 | 0.110 |
Why?
|
| Receptors, Interleukin-18 | 1 | 2013 | 25 | 0.110 |
Why?
|
| Esophageal Atresia | 1 | 2016 | 225 | 0.110 |
Why?
|
| Scurvy | 1 | 2013 | 36 | 0.110 |
Why?
|
| Acid Anhydride Hydrolases | 1 | 2013 | 67 | 0.110 |
Why?
|
| Membrane Proteins | 2 | 2013 | 7895 | 0.110 |
Why?
|
| Single-Blind Method | 1 | 2016 | 1585 | 0.100 |
Why?
|
| Prospective Studies | 4 | 2018 | 54913 | 0.100 |
Why?
|
| Humans | 25 | 2024 | 768369 | 0.100 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2017 | 18047 | 0.100 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2013 | 262 | 0.100 |
Why?
|
| Neural Pathways | 1 | 2003 | 3122 | 0.100 |
Why?
|
| Perioperative Care | 1 | 2019 | 1046 | 0.100 |
Why?
|
| Infant | 4 | 2024 | 36496 | 0.090 |
Why?
|
| DNA Repair Enzymes | 1 | 2013 | 347 | 0.090 |
Why?
|
| Hippocampus | 3 | 2003 | 3783 | 0.090 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2017 | 1368 | 0.090 |
Why?
|
| Interleukin-13 | 1 | 2013 | 392 | 0.090 |
Why?
|
| Catheterization, Central Venous | 1 | 2015 | 530 | 0.090 |
Why?
|
| Cohort Studies | 3 | 2018 | 41782 | 0.090 |
Why?
|
| Male | 10 | 2024 | 364761 | 0.080 |
Why?
|
| Female | 10 | 2024 | 396926 | 0.080 |
Why?
|
| Heart Atria | 1 | 2015 | 1361 | 0.080 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2013 | 600 | 0.080 |
Why?
|
| Genetic Loci | 2 | 2017 | 2630 | 0.070 |
Why?
|
| DNA Copy Number Variations | 1 | 2016 | 2046 | 0.070 |
Why?
|
| Curriculum | 1 | 2018 | 3778 | 0.060 |
Why?
|
| Myelin-Associated Glycoprotein | 1 | 2005 | 110 | 0.060 |
Why?
|
| Antiviral Agents | 1 | 2017 | 3062 | 0.060 |
Why?
|
| Semaphorins | 1 | 2004 | 96 | 0.060 |
Why?
|
| Length of Stay | 1 | 2018 | 6521 | 0.060 |
Why?
|
| Vitamin D Deficiency | 1 | 2013 | 1389 | 0.060 |
Why?
|
| Genetic Association Studies | 1 | 2013 | 2742 | 0.060 |
Why?
|
| Retrospective Studies | 3 | 2024 | 81835 | 0.050 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 20232 | 0.050 |
Why?
|
| Physicians | 1 | 2021 | 4615 | 0.050 |
Why?
|
| Adenoviridae | 2 | 1998 | 1098 | 0.050 |
Why?
|
| Neurons | 3 | 2003 | 9504 | 0.050 |
Why?
|
| Diagnosis, Differential | 1 | 2018 | 13025 | 0.050 |
Why?
|
| Mesencephalon | 1 | 2004 | 339 | 0.050 |
Why?
|
| Program Development | 2 | 2019 | 1296 | 0.050 |
Why?
|
| Hypertension, Pulmonary | 1 | 2013 | 1605 | 0.050 |
Why?
|
| Organ Culture Techniques | 1 | 2004 | 796 | 0.050 |
Why?
|
| Histamine | 1 | 2023 | 500 | 0.050 |
Why?
|
| Neoplasm Proteins | 1 | 2013 | 3611 | 0.050 |
Why?
|
| Disease Progression | 1 | 2018 | 13643 | 0.050 |
Why?
|
| Clinical Competence | 1 | 2016 | 4841 | 0.050 |
Why?
|
| Cricetinae | 3 | 2005 | 2423 | 0.040 |
Why?
|
| Prognosis | 2 | 2019 | 30031 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2018 | 65408 | 0.040 |
Why?
|
| Genotype | 1 | 2013 | 13045 | 0.040 |
Why?
|
| Credentialing | 1 | 2018 | 114 | 0.040 |
Why?
|
| Hospitalization | 1 | 2018 | 10845 | 0.040 |
Why?
|
| Genetic Vectors | 2 | 1998 | 3417 | 0.040 |
Why?
|
| CHO Cells | 2 | 1998 | 1382 | 0.040 |
Why?
|
| Rhinitis, Allergic, Seasonal | 1 | 2017 | 105 | 0.040 |
Why?
|
| Myristic Acid | 1 | 1996 | 49 | 0.040 |
Why?
|
| Myristic Acids | 1 | 1996 | 49 | 0.040 |
Why?
|
| Histone Code | 1 | 2017 | 160 | 0.030 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1997 | 492 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2013 | 9623 | 0.030 |
Why?
|
| Limb Deformities, Congenital | 1 | 2016 | 136 | 0.030 |
Why?
|
| Receptors, Cell Surface | 1 | 2005 | 2818 | 0.030 |
Why?
|
| Tracheoesophageal Fistula | 1 | 2016 | 130 | 0.030 |
Why?
|
| Potassium Channels | 1 | 1998 | 538 | 0.030 |
Why?
|
| Time Factors | 1 | 2016 | 40271 | 0.030 |
Why?
|
| Pyramidal Cells | 1 | 1997 | 367 | 0.030 |
Why?
|
| Workflow | 1 | 2019 | 861 | 0.030 |
Why?
|
| Anal Canal | 1 | 2016 | 376 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2016 | 752 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2019 | 15638 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2004 | 8201 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2013 | 16023 | 0.030 |
Why?
|
| Cytosol | 1 | 1996 | 889 | 0.030 |
Why?
|
| Rats | 3 | 2005 | 23839 | 0.030 |
Why?
|
| Ion Channels | 1 | 1998 | 1044 | 0.030 |
Why?
|
| Cell Line | 2 | 2004 | 15610 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 10784 | 0.030 |
Why?
|
| Animals | 7 | 2023 | 169424 | 0.030 |
Why?
|
| Transfection | 2 | 1998 | 5767 | 0.020 |
Why?
|
| Mice | 4 | 2023 | 82051 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2023 | 4570 | 0.020 |
Why?
|
| Esophagus | 1 | 2016 | 1045 | 0.020 |
Why?
|
| Synaptic Transmission | 1 | 1996 | 1173 | 0.020 |
Why?
|
| Trachea | 1 | 2016 | 1095 | 0.020 |
Why?
|
| Young Adult | 1 | 2016 | 60038 | 0.020 |
Why?
|
| Fellowships and Scholarships | 1 | 2018 | 1134 | 0.020 |
Why?
|
| Leukocytes | 1 | 2017 | 2030 | 0.020 |
Why?
|
| Spine | 1 | 2016 | 1142 | 0.020 |
Why?
|
| Synapses | 1 | 1998 | 1766 | 0.020 |
Why?
|
| Down Syndrome | 1 | 2016 | 914 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1996 | 3735 | 0.020 |
Why?
|
| Cell Membrane | 1 | 1996 | 3663 | 0.020 |
Why?
|
| Alleles | 1 | 2017 | 6880 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2017 | 5803 | 0.020 |
Why?
|
| Risk | 1 | 2017 | 9642 | 0.020 |
Why?
|
| Kidney | 2 | 2016 | 7064 | 0.010 |
Why?
|
| N-Acetylneuraminic Acid | 1 | 2005 | 175 | 0.010 |
Why?
|
| Myelin Proteins | 1 | 2005 | 212 | 0.010 |
Why?
|
| Epigenesis, Genetic | 1 | 2017 | 3832 | 0.010 |
Why?
|
| Membrane Microdomains | 1 | 2005 | 205 | 0.010 |
Why?
|
| Receptors, Peptide | 1 | 2005 | 280 | 0.010 |
Why?
|
| Delivery of Health Care | 1 | 2021 | 5367 | 0.010 |
Why?
|
| GPI-Linked Proteins | 1 | 2005 | 473 | 0.010 |
Why?
|
| Cricetulus | 1 | 2005 | 815 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2019 | 15459 | 0.010 |
Why?
|
| Neurites | 1 | 2005 | 391 | 0.010 |
Why?
|
| Pregnancy | 1 | 2004 | 30179 | 0.010 |
Why?
|
| Age Factors | 1 | 2019 | 18477 | 0.010 |
Why?
|
| Feeding Behavior | 1 | 2013 | 3202 | 0.010 |
Why?
|
| Heart Defects, Congenital | 1 | 2016 | 4713 | 0.010 |
Why?
|
| Phenotype | 1 | 2017 | 16712 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2005 | 2696 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2017 | 12771 | 0.010 |
Why?
|
| Cerebellum | 1 | 2005 | 1515 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2018 | 26348 | 0.010 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 1997 | 178 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2016 | 26394 | 0.010 |
Why?
|
| Adenoviruses, Human | 1 | 1998 | 257 | 0.010 |
Why?
|
| DNA Primers | 1 | 1998 | 2825 | 0.010 |
Why?
|
| Protein Binding | 1 | 2005 | 9376 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1998 | 4174 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 1997 | 1743 | 0.010 |
Why?
|
| Brain | 1 | 1998 | 27439 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2005 | 19035 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 1998 | 6087 | 0.000 |
Why?
|
| Recombinant Proteins | 1 | 1998 | 6527 | 0.000 |
Why?
|
| Phosphorylation | 1 | 1997 | 8331 | 0.000 |
Why?
|
| Immunohistochemistry | 1 | 1997 | 11139 | 0.000 |
Why?
|